Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis

Published:2019-11-11 Issue:2 Volume:287 Page:171-179
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Scholle O.¹^ORCID,Kollhorst B.²^ORCID,Haug U.¹³^ORCID

Affiliation:

1. From the Department of Clinical EpidemiologyLeibniz Institute for Prevention Research and Epidemiology—BIPS BremenGermany

2. Department of Biometry and Data Management Leibniz Institute for Prevention Research and Epidemiology—BIPS BremenGermany

3. Faculty of Human and Health Sciences University of Bremen Bremen Germany

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.12990

Reference22 articles.

1. The Coxibs, Selective Inhibitors of Cyclooxygenase-2

2. Failing the Public Health — Rofecoxib, Merck, and the FDA

3. Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks

4. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

5. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Evidence on Diclofenac: Implications for Cardiovascular Safety;Cardiovascular Drugs and Therapy;2024-07-31

2. Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro;Drugs & Therapy Perspectives;2024-02

3. Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: Retrospective, national, drug utilization study;Vojnosanitetski pregled;2023

4. Pharmacoepidemiology;Handbook of Epidemiology;2022

5. Perioperative Schmerztherapie mit Nichtopioidanalgetika;Der Anaesthesist;2021-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3